DEXCOM INC (DXCM) Stock Income Statement
NASDAQ:DXCM - Nasdaq - US2521311074 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.30B | 4.03B | 3.62B | 2.91B | 2.45B | |||
| Cost Of Goods | 1.72B | 1.54B | 1.32B | 1.01B | 739.90M | |||
| Gross Profit | 2.58B | 2.49B | 2.31B | 1.90B | 1.71B | |||
| Operating Expenses | 1.84B | 1.84B | 1.69B | 1.49B | 1.41B | |||
| Research and Development | 568.30M | 552.40M | 505.80M | 484.20M | 604.20M | |||
| Selling, General, and Administrative Expenses | 1.27B | 1.29B | 1.18B | 1.00B | 806.80M | |||
| Operating Income | 740.70M | 653.50M | 614.30M | 405.10M | 293.90M | |||
| Interest Income/Expense | 99.20M | 115.20M | 116.60M | -400.00K | -8.90M | |||
| Other Income/Expense | -2.30M | -6.20M | -3.90M | N/A | N/A | |||
| Non Recurring Items | N/A | -53.50M | -16.60M | -13.90M | -28.20M | |||
| Income Before Taxes | 784.10M | 709.00M | 710.40M | 390.80M | 256.80M | |||
| Income Tax | 212.60M | 132.80M | 168.90M | 49.60M | 39.90M | |||
| Net Income | 571.50M | 576.20M | 541.50M | 341.20M | 216.90M | |||
| EBITDA | 976.80M | 871.20M | 800.30M | 561.00M | 395.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.40 | 1.40 | 1.27 | 0.80 | 0.51 | |||
| Non GAAP EPS | 1.70 | 1.65 | 1.51 | 0.87 | 0.67 | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.01% | 61.78% | 63.65% | 65.19% | 69.78% | |||
| Profit Margin | 13.29% | 14.29% | 14.95% | 11.73% | 8.86% | |||
| Operating Profit Margin | 17.22% | 16.20% | 16.96% | 13.92% | 12.00% | |||
All data in USD